임상

HOME > 연구실적 > 임상 > 논문
 
작성일 : 17-03-17 17:52
논문번호 190
논문제목(영문) Outcomes of Acute Myocardial Infarction Patients Implanted With Biodegradable Polymer Biolimus-Eluting Stents Versus New-Generation Durable Polymer Drug-Eluting Stents: A Retrospective Analysis
국내외구분 국외 SCI여부 SCI
연구책임자역할 공저자
주저자명 Choe JC
교신저자명 Cha KS
공동저자명 Choe JC, Cha KS, Jang HY, Choi JH, Kim BW, Ahn J, Park JS, Lee HW, Oh JH, Choi JH, Lee HC, Hong TJ, Ahn Y, Jeong MH; Korea Acute Myocardial Infarction Registry Investigators.
게제년월일 2016-11-20
ISSN 0003-3197
Impact Factor 2.931
학술지명 Angiology.
서지사항 N집 / N권 / N호,   페이지(N - N)
요약초록문
(Abstract) 입력		 We compared outcomes between biodegradable polymer biolimus-eluting stent (BP-BES) and new-generation durable polymer drug-eluting stent (DP-DES) implantations in patients with acute myocardial infarction (MI). Among 13472 patients with acute MI in a nationwide registry, 557 (64.8%) were in the BP-BES and 303 (35.2%) in the new-generation DP-DES group following coronary reperfusion. The occurrence of major adverse cardiac events (MACE; death, MI, revascularization) and stent thrombosis was compared. Major adverse cardiac events occurred in 53 (6.2%) patients and showed similar rates between the BP-BES and new-generation DP-DES groups (all: 6.6% vs 5.9%, P = .652; propensity score [PS] matched: n = 380, 6.3% vs 5.3%, P = .623). Stent thrombosis did not differ between groups (all: 0.3% vs 0.4%, P = .892; PS matched: 0.5% vs 0.5%, P = 1.000). Major adverse cardiac event-free survival was comparable between groups (all: 93.4% vs 94.1%, log-rank P = .357; PS matched: 93.7% vs 94.7%, log-rank P = .445). Biodegradable polymer biolimus-eluting stent was not associated with MACE (all: hazard ratio [HR], 1.67; 95% confidence interval [CI], 0.75-3.74; P = 0.212; PS matched: HR, 1.05; 95% CI, 0.40-2.75; P = .915). In conclusion, in patients with acute MI, BP-BES was equivalent to the new-generation DP-DES in terms of outcomes.
파일